Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Twice daily
MoneyWeek
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Four times a week
Look After My Bills
Sign up to our free money-saving newsletter, filled with the latest news and expert advice to help you find the best tips and deals for managing your bills. Start saving today!
Five to buy
JD Sports Fashion
(Investors’ Chronicle) JD Sports Fashion has benefited from the US government’s stimulus package: the American business produced over half of the group’s pre-tax profit of £439.5m in the first six months of 2021. That’s a sevenfold increase from the same period last year and 177% higher than in 2019. The group has completed a string of successful acquisitions across the US, Poland, Spain and Britain, which have helped drive growth. Its core UK and Ireland business did well despite new lockdowns; when shops were closed in the spring it made 90% of the sales it generated in the same period in 2019 from online sales. The firm remains cautious, forgoing an interim dividend in case of further lockdowns, but a larger full-year dividend is in prospect should positive trading continue. 1,151p
Darktrace
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
(The Daily Telegraph) Around 15% of cybersecurity company Darktrace’s shares are owned by Mike Lynch, “a man accused of a multibillion dollar fraud”. But there is no sign of dubious practice at Darktrace. Since it listed in April the stock has tripled. The company faces stiff competition from American rivals. But it stands out because its software analyses users instead of devices, providing customers with a “map”, or visualisation, of their networks that makes it easier to spot anomalies. The firm has plenty of potential, and taking “a small punt” on it at this stage could pay off. 728p
Artisanal Spirits Company
(The Mail on Sunday) The Scotch Malt Whisky Society was founded in 1983 by Edinburgh’s Pip Hills and 12 of his friends, so that they could buy and enjoy casks of whisky. It now boasts 29,000 members and listed on Aim in June as the Artisanal Spirits Company. Members pay around £65 a year and most buy at least seven bottles averaging £75 each. First half figures for 2021 revealed sales of £7.9m, a 20% year-on-year rise. Analysts expect revenues of £17.5m for 2021 and £21m next year. The group is expected to be profitable from next year and the whisky market is booming. The shares have dipped recently, but given the firm’s solid prospects, they should recover. 83p
CVC
(The Sunday Times) Pets have become a big business following the pandemic. Complex procedures and “posh pet food” have become widely available, driving rapid growth among insurers, pet shops and veterinary practices. CVS Group is an Aim-listed owner of vet surgeries. It recently acquired a majority stake in vet chain Medivet for £1bn and will continue to concentrate on acquisitions. Like-for-like sales for the 12 months to June jumped by 17.4%. For now, at least, pet owners are spending large sums on their animals while taking out insurance for them, too. The coming months will reveal whether the pet trend begins to slow, but if CVS continues to perform, it is one to buy. 2,490p
Chemring
(Shares) Defence group Chemring says its order book has grown, “providing visibility” for the remainder of the year and fuelling confidence that it will meet analysts’ expectations for the year to 31 October. The order book was valued at £464m in August, up from £450m at the end of April. The company’s cybersecurity subsidiary, Roke, should keep flourishing as the sector expands: further double-digit growth is expected. Orders for 2022 are building too. The stock’s quality and “ongoing resilience” make it a buy. 328p
...and the rest
The Daily Telegraph
B&Q owner Kingfisher’s like-for-like sales were 5% higher year-on-year in June, compared with a 2% rise for the overall market. The group has an “above average” chance of maintaining its edge over rivals. Lockdown was a huge boost for home improvement and the pandemic introduced many people to “the joys of DIY”. Hold (371p).
Shares
Recent acquisitions by refuse-specialist Biffa have cemented its lead in waste-recycling. It has recovered from the crisis more rapidly than expected: revenue for the first five months of the year to 31 August was 12% higher than in the same period of 2019. Earnings forecasts for 2022 and 2023 have risen strongly recently. Buy (385p).
Investors’ Chronicle
Higher demand from private patients boosted operating profits at Spire Healthcare Group, Britain’s second-biggest private provider, to £46.2m in the six months to 30 June 2021; the previous year it made a loss. Demand should remain robust. Hold (236p).
The Mail on Sunday
Palm oil “is a controversial commodity” but Indonesia-based MP Evans prides itself on sustainable production, proper treatment of workers and supporting local communities. The company looks after investors too: it has maintained or increased its dividend every year for the last 25 years. The firm has announced a 588% increase in half-year profits to £30m and a doubling of the interim dividend to 10p. It has also pledged to increase the annual dividend by 36% to 30p. Existing shareholders should hold, and new investors “could dip their toes in”(788p).
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
MoneyWeek is written by a team of experienced and award-winning journalists, plus expert columnists. As well as daily digital news and features, MoneyWeek also publishes a weekly magazine, covering investing and personal finance. From share tips, pensions, gold to practical investment tips - we provide a round-up to help you make money and keep it.
-
How a ‘great view’ from your home can boost its value by 35%A house that comes with a picturesque backdrop could add tens of thousands of pounds to its asking price – but how does each region compare?
-
What is a care fees annuity and how much does it cost?How we will be cared for in our later years – and how much we are willing to pay for it – are conversations best had as early as possible. One option to cover the cost is a care fees annuity. We look at the pros and cons.
-
Three key winners from the AI boom and beyondJames Harries of the Trojan Global Income Fund picks three promising stocks that transcend the hype of the AI boom
-
RTX Corporation is a strong player in a growth marketRTX Corporation’s order backlog means investors can look forward to years of rising profits
-
Profit from MSCI – the backbone of financeAs an index provider, MSCI is a key part of the global financial system. Its shares look cheap
-
'AI is the real deal – it will change our world in more ways than we can imagine'Interview Rob Arnott of Research Affiliates talks to Andrew Van Sickle about the AI bubble, the impact of tariffs on inflation and the outlook for gold and China
-
Should investors join the rush for venture-capital trusts?Opinion Investors hoping to buy into venture-capital trusts before the end of the tax year may need to move quickly, says David Prosser
-
Food and drinks giants seek an image makeover – here's what they're doingThe global food and drink industry is having to change pace to retain its famous appeal for defensive investors. Who will be the winners?
-
Barings Emerging Europe trust bounces back from Russia woesBarings Emerging Europe trust has added the Middle East and Africa to its mandate, delivering a strong recovery, says Max King
-
How a dovish Federal Reserve could affect youTrump’s pick for the US Federal Reserve is not so much of a yes-man as his rival, but interest rates will still come down quickly, says Cris Sholto Heaton
